Z. B. Erton Et Al. , "Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry")," LUPUS , vol.31, no.14, pp.1770-1776, 2022
Erton, Z. B. Et Al. 2022. Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry"). LUPUS , vol.31, no.14 , 1770-1776.
Erton, Z. B., Leaf, R. K., de Andrade, D., Clarke, A. E., Tektonidou, M. G., Pengo, V., ... Sciascia, S.(2022). Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry"). LUPUS , vol.31, no.14, 1770-1776.
Erton, Zeynep Et Al. "Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry")," LUPUS , vol.31, no.14, 1770-1776, 2022
Erton, Zeynep B. Et Al. "Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry")." LUPUS , vol.31, no.14, pp.1770-1776, 2022
Erton, Z. B. Et Al. (2022) . "Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry")." LUPUS , vol.31, no.14, pp.1770-1776.
@article{article, author={Zeynep B. Erton Et Al. }, title={Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry")}, journal={LUPUS}, year=2022, pages={1770-1776} }